Long‐term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7‐year results from the PRECiSE 3 study
暂无分享,去创建一个
D. Schwartz | W. Sandborn | G. Lichtenstein | C. Randall | S. D. Lee | A. Gutierrez | S. Ambarkhane | C. Kayhan | B. Pierre-Louis | S. Schreiber | D. A. Schwartz | S. Schreiber | W. Sandborn | S. Lee | Alexandra M. Gutierrez